Recently, there has been a resurgence of interest in platinum-based chemotherapy [7] including the use of platinum in patients with BRCA1-associated breast cancer which is known for its germline deficiency in DNA damage repair via homologous recombination (HR) [8]. Here, BRCA1 is linked to breast carcinoma.